O, A., A, B., R, T., S, L., S, P., & B, T. (2025). The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease. Medicina (Kaunas, Lithuania), 61(10), . https://doi.org/10.3390/medicina61101850
Chicago Style (17th ed.) CitationO, Albai, Braha A, Timar R, Lazăr S, Popescu S, and Timar B. "The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease." Medicina (Kaunas, Lithuania) 61, no. 10 (2025). https://doi.org/10.3390/medicina61101850.
MLA (9th ed.) CitationO, Albai, et al. "The Impact of Antidiabetic Therapy on Liver Injury, Steatosis, and Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease." Medicina (Kaunas, Lithuania), vol. 61, no. 10, 2025, https://doi.org/10.3390/medicina61101850.